Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 21, 2021 | Oryzon Announces $1 Million Grant from Kabuki Syndrome Philanthropists to Support A Precision Medicine Phase I/Ii Trial with Vafidemstat | Oryzon Genomics, S. A announced that it has received a one million USD grant to support a new clinical trial with company Phase II LSD1 inhibitor vafidemstat in patients with Kabuki syndrome (KS). The grant was awarded by a patient family w... |
Reviews 0
FAQ about Welcome oryzoncredit.com
What has the press written about Welcome oryzoncredit.com?
Parsers VC has collected 2 articles mentioning Welcome oryzoncredit.com, among them “Oryzon Announces $1 Million Grant from Kabuki Syndrome Philanthropists to Support A Precision Medicine Phase I/Ii Trial with Vafidemstat” (Sep 21, 2021).
Is Welcome oryzoncredit.com still active?
Yes, Welcome oryzoncredit.com is active; its latest activity on Parsers VC dates from Jul 5, 2022.